XT
INO icon

XTX Topco’s Inovio Pharmaceuticals INO Stock Holding History

XTX Topco’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Sell
105,833
-106,844
-50% -$127K ﹤0.01% 3478
2026
Q1 		$370K Buy
212,677
+45,640
+27% +$75.1K 0.01% 2296
2025
Q4 		$291K Sell
167,037
-43,530
-21% -$95.9K 0.01% 2100
2025
Q3 		$493K Buy
210,567
+188,529
+855% +$361K 0.03% 1083
2025
Q2 		$44.8K Sell
22,038
-44,131
-67% -$84.6K ﹤0.01% 2032
2025
Q1 		$108K Buy
66,169
+13,939
+27% +$28K 0.01% 1855
2024
Q4 		$95.6K Buy
+52,230
New +$231K 0.01% 1777
2024
Q1 		– Sell
-4,650
Closed -$28.5K – 2065
2023
Q4 		$28.5K Buy
+4,650
New +$23K 0.01% 1319
2021
Q3 		– Sell
-879
Closed -$98K – 855
2021
Q2 		$98K Buy
+879
New +$84.4K 0.03% 663

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

XTX Topco's INO Position: Q2 2026 in Review

XTX Topco reduced its Inovio Pharmaceuticals (INO) stake by 50% in Q2 2026, selling an estimated $127K and leaving 105,833 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #3478.

XTX Topco first reported a position in INO in Q2 2021 and has held it in 9 quarters since. The position peaked at $493K in Q3 2025. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • XTX Topco held 105,833 shares of Inovio Pharmaceuticals worth $116K as of Q2 2026.
  • XTX Topco sold 106,844 Inovio Pharmaceuticals shares in Q2 2026, an estimated $127K.
  • Inovio Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3478 holding.
  • XTX Topco first reported a position in Inovio Pharmaceuticals in Q2 2021 and has held it in 9 quarters since.
  • XTX Topco's Inovio Pharmaceuticals position peaked at $493K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.